356 related articles for article (PubMed ID: 24969458)
1. [Induction in vitro and stability of Mycobacterium tuberculosis resistance to ofloxacin].
Yang H; Hu Z; Sha W; Lu J; Cui Z; Wang J; Huang X; Xiao H
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):318-23. PubMed ID: 24969458
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
Singh P; Jain A; Dixit P; Prakash S; Jaiswal I; Venkatesh V; Singh M
J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485
[TBL] [Abstract][Full Text] [Related]
3. Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates.
Sun Z; Zhang J; Zhang X; Wang S; Zhang Y; Li C
Int J Antimicrob Agents; 2008 Feb; 31(2):115-21. PubMed ID: 18164184
[TBL] [Abstract][Full Text] [Related]
4. Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.
Kambli P; Ajbani K; Sadani M; Nikam C; Shetty A; Udwadia Z; Rodwell TC; Catanzaro A; Rodrigues C
Tuberculosis (Edinb); 2015 Mar; 95(2):137-41. PubMed ID: 25522842
[TBL] [Abstract][Full Text] [Related]
5. Performance of Sequencing in Predicting Ofloxacin Resistance in
Wang Z; Xie T; Mu C; Sun R; Wang C; Zhao H; Ju H
Ann Clin Lab Sci; 2018 Jan; 48(1):69-74. PubMed ID: 29530999
[TBL] [Abstract][Full Text] [Related]
6. Molecular characteristics of ofloxacin mono-resistant Mycobacterium tuberculosis isolates from new and previously treated tuberculosis patients.
Wang Z; Xie T; Mu C; Wang C; Ju H; Zhao H; Sun R
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28317169
[TBL] [Abstract][Full Text] [Related]
7. Analysis of fluoroquinolone resistance in clinical isolates of Mycobacterium tuberculosis from India.
Sulochana S; Narayanan S; Paramasivan CN; Suganthi C; Narayanan PR
J Chemother; 2007 Apr; 19(2):166-71. PubMed ID: 17434825
[TBL] [Abstract][Full Text] [Related]
8. Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility.
Kam KM; Yip CW; Cheung TL; Tang HS; Leung OC; Chan MY
Microb Drug Resist; 2006; 12(1):7-11. PubMed ID: 16584301
[TBL] [Abstract][Full Text] [Related]
9. Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus.
Arjomandzadegan M; Titov L; Farnia P; Owlia P; Ranjbar R; Sheikholeslami F; Surkova L
Int J Mycobacteriol; 2016 Sep; 5(3):299-305. PubMed ID: 27847014
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
[TBL] [Abstract][Full Text] [Related]
11. gyrA and gyrB mutations in ofloxacin-resistant Mycobacterium tuberculosis clinical isolates in Thailand.
Pitaksajjakul P; Worakhunpiset S; Chaiprasert A; Boonyasopun J; Ramasoota P
Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1163-7. PubMed ID: 22299442
[TBL] [Abstract][Full Text] [Related]
12. Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
Chen J; Chen Z; Li Y; Xia W; Chen X; Chen T; Zhou L; Xu B; Xu S
Braz J Infect Dis; 2012; 16(2):136-41. PubMed ID: 22552454
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
Nosova EY; Bukatina AA; Isaeva YD; Makarova MV; Galkina KY; Moroz AM
J Med Microbiol; 2013 Jan; 62(Pt 1):108-113. PubMed ID: 23019190
[TBL] [Abstract][Full Text] [Related]
14. Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin.
Yu X; Wang G; Chen S; Wei G; Shang Y; Dong L; Schön T; Moradigaravand D; Parkhill J; Peacock SJ; Köser CU; Huang H
Antimicrob Agents Chemother; 2016 Sep; 60(9):5232-7. PubMed ID: 27324769
[TBL] [Abstract][Full Text] [Related]
15. gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.
Sirgel FA; Warren RM; Streicher EM; Victor TC; van Helden PD; Böttger EC
J Antimicrob Chemother; 2012 May; 67(5):1088-93. PubMed ID: 22357804
[TBL] [Abstract][Full Text] [Related]
16. Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Chien JY; Chiu WY; Chien ST; Chiang CJ; Yu CJ; Hsueh PR
Antimicrob Agents Chemother; 2016 Apr; 60(4):2090-6. PubMed ID: 26787695
[TBL] [Abstract][Full Text] [Related]
17. [Molecular characterization of drug-resistant and extensive-drug resistant isolates of Mycobacterium tuberculosis in Shenzhen of China].
Gui J; Wang F; Luo DQ; Wang HF; Peng Y; Zhang L
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):276-9. PubMed ID: 20646459
[TBL] [Abstract][Full Text] [Related]
18. Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels.
Chernyaeva E; Fedorova E; Zhemkova G; Korneev Y; Kozlov A
Tuberculosis (Edinb); 2013 May; 93(3):291-5. PubMed ID: 23491718
[TBL] [Abstract][Full Text] [Related]
19.
Tudó G; Lopez-Gavin A; Portell-Buj E; Freixes J; Vila J; Roman A; Monté MR; Gonzalez-Martin J
Microb Drug Resist; 2020 Sep; 26(9):1019-1022. PubMed ID: 32159449
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis.
Qiao M; Ren W; Guo H; Huo F; Shang Y; Wang Y; Gao M; Pang Y
Int J Infect Dis; 2021 May; 106():295-299. PubMed ID: 33864922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
